Indeed, we found that that AGTR1 overexpression, in both breast cancer patient samples and breast cancer cell lines, drives NF-κB activation and an associated NF-κB gene expression signature; as we expected, CARMA3, Bcl10, and MALT1 are each required for this to occur (Table 1A) (50). Here, AGTR1 is linked to breast cancer.